Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kalvista Pharmaceuticals, Ltd.

Clinical trials sponsored by Kalvista Pharmaceuticals, Ltd., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

New oral medication shows promise for controlling rare swelling disorder

Disease control Ongoing

This study is testing the long-term safety of an oral medication called KVD900 for treating sudden swelling attacks in people with hereditary angioedema. The trial includes 145 adolescents and adults who have type I or II hereditary angioedema and have previously participated in …

Phase: PHASE3 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control

Last updated Apr 02, 2026 05:42 UTC